Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France"
Saved in:
Main Authors: | Matthieu Lehmann (Author), Jean-Luc Pouly (Author), Paul Barrière (Author), Lauren Amy Boland (Author), Samuel George Bean (Author), Julian Jenkins (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France
by: Matthieu Lehmann, et al.
Published: (2024) -
A letter to editor - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France."
by: Juan-Enrique Schwarze, et al.
Published: (2024) -
Major results of a phase III comparative multicenter study on the follitropin alfa biosimilar (Primapur®) and the original follitropin alfa (Gonal-f®)
by: Z. B. Barakhoeva, et al.
Published: (2018) -
A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility
by: Gizzo S, et al.
Published: (2016) -
In vitro fertilization cycles stimulated with follitropin delta result in similar embryo development and quality when compared with cycles stimulated with follitropin alfa or follitropin beta
by: Olga Haakman, M.D, et al.
Published: (2021)